Results - Page 7

GSK on track to deliver 2024 outlooks with further good progress made in R&D Q3 2024 sales and core earnings growth driven by strong…

SOFTCAT plc (‘Softcat’, the ‘Group’) Preliminary results for the year ended 31 July 2024 Strong operating and financial performance drives another year of profitable…

RESULTS FOR THE NINE MONTHS ENDED 30 SEPTEMBER 2024 “The Group delivered a robust financial performance in the third quarter of 2024, with growth…

GSK announces positive phase III results from ANCHOR trials for depemokimab in chronic rhinosinusitis with nasal polyps ·  Primary endpoints met with statistically significant reduction in…

The following is an update to the third quarter 2024 outlook and gives an overview of our current expectations for the third quarter. Outlooks…

18 September 2024 MJ Gleeson plc (GLE.L) (“Gleeson” or “the Group” or “the Company”) Audited results for the year ended 30 June 2024 (“FY2024”)…

Strong sales, a prime portfolio and an improving outlook underpin increased dividend Henry Boot PLC, a Company engaged in land promotion, property investment and…

Aviva plc 2024 Interim Results Announcement Dividend declaration Ordinary shares of 32 17/19 pence Aviva plc (the Company) announces an interim dividend of 11.9 pence per…